{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T19:21:21Z","timestamp":1789154481404,"version":"build-2803163510"},"reference-count":27,"publisher":"American Chemical Society (ACS)","issue":"18","license":[{"start":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:00:00Z","timestamp":1757548800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:00:00Z","timestamp":1757548800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:00:00Z","timestamp":1757548800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22277154"],"award-info":[{"award-number":["22277154"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22507157"],"award-info":[{"award-number":["22507157"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2514050001380"],"award-info":[{"award-number":["2514050001380"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,25]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Myocardial fibrosis contributes to heart failure (HF) progression, which is associated with impaired nitric oxide (NO)\u2013soluble guanylyl cyclase (sGC)\u2013cyclic guanosine monophosphate (cGMP) signaling. Hydrogen sulfide (H2S), a cardioprotective gasotransmitter, is reduced in patients with HF. Therapeutic options targeting both sGC activation and H2S enhancement remain limited. We have developed a novel carbonyl sulfide (COS)\/H2S-donor hybrid sGC stimulator, COS-A, which exhibits a well-characterized H2S-releasing property. Compound COS-A outperformed vericiguat in sGC activation in vitro and reduced fibrosis in transforming growth factor-beta 1 (TGF-\u03b21)-treated cardiac fibroblasts by increasing cGMP and H2S levels. In isoproterenol (ISO)-induced HF mice, COS-A improved cardiac function comparably to vericiguat. Histological findings revealed its antifibrotic effects through sGC activation and elevation of H2S. Our findings indicate that this COS\/H2S-donor hybridized sGC stimulator holds therapeutic promise for HF treatment.<\/jats:p>","DOI":"10.1021\/acs.jmedchem.5c02191","type":"journal-article","created":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T22:12:36Z","timestamp":1757628756000},"page":"19781-19790","source":"Crossref","is-referenced-by-count":3,"title":["Discovery of\na Novel COS\/H2S-Donor\nHybridized sGC Stimulator for Alleviating Isoproterenol-Induced Myocardial\nFibrosis"],"prefix":"10.1021","volume":"68","author":[{"given":"Yi","family":"Yang","sequence":"first","affiliation":[{"name":"Sun Yat-sen University , , ,","place":["Guangzhou, China, 510006"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiafei","family":"Wu","sequence":"additional","affiliation":[{"name":"Sun Yat-sen University , , ,","place":["Guangzhou, China, 510006"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gongyun","family":"He","sequence":"additional","affiliation":[{"name":"Sun Yat-sen University , , ,","place":["Shenzhen, China, 518107"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqi","family":"Yao","sequence":"additional","affiliation":[{"name":"Sun Yat-sen University , , ,","place":["Guangzhou, China, 510006"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Yuan","family":"Wei","sequence":"additional","affiliation":[{"name":"Sun Yat-sen University , , ,","place":["Guangzhou, China, 510006"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Wang","sequence":"additional","affiliation":[{"name":"Third Affiliated Hospital of Sun Yat-sen University , ,","place":["Guangzhou, China, 510630"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Dai","sequence":"additional","affiliation":[{"name":"Third Affiliated Hospital of Sun Yat-sen University , ,","place":["Guangzhou, China, 510630"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Yuan","sequence":"additional","affiliation":[{"name":"Sun Yat-sen University , , ,","place":["Guangzhou, China, 510006"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwen","family":"Chen","sequence":"additional","affiliation":[{"name":"Sun Yat-sen University , , ,","place":["Guangzhou, China, 510006"]},{"name":"Sun Yat-sen University Nanchang Research Institute , ,","place":["Nanchang, China, 330096"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Wang","sequence":"additional","affiliation":[{"name":"Third Affiliated Hospital of Sun Yat-sen University , ,","place":["Guangzhou, China, 510630"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1905-1364","authenticated-orcid":true,"given":"Lei","family":"Guo","sequence":"additional","affiliation":[{"name":"Sun Yat-sen University , , ,","place":["Guangzhou, China, 510006"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2025,9,11]]},"reference":[{"key":"2026073102164060200_cit1","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/s41392-022-00972-6","article-title":"Signaling\ncascades in the failing heart and emerging therapeutic strategies","volume":"7","author":"He","year":"2022","journal-title":"Signal Transduction Targeted Ther."},{"issue":"36","key":"2026073102164060200_cit2","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"ESC Guidelines for\nthe diagnosis and treatment of acute and chronic heart failure: Developed\nby the Task Force for the diagnosis and treatment of acute and chronic\nheart failure of the European Society of Cardiology (ESC) With the\nspecial contribution of the Heart Failure Association (HFA) of the\nESC","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur. Heart J."},{"key":"2026073102164060200_cit3","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1007\/s10741-022-10239-5","article-title":"Therapeutic augmentation\nof NO\u2013sGC\u2013cGMP signalling: lessons learned from pulmonary\narterial hypertension and heart failure","volume":"27","author":"Triposkiadis","year":"2022","journal-title":"Heart\nFailure Rev."},{"key":"2026073102164060200_cit4","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1080\/14656566.2021.1937121","article-title":"Vericiguat for the treatment of heart\nfailure: mechanism of action and pharmacological properties compared\nwith other emerging therapeutic options","volume":"22","author":"Hulot","year":"2021","journal-title":"Expert\nOpin. Pharmacother."},{"key":"2026073102164060200_cit5","doi-asserted-by":"publisher","first-page":"662","DOI":"10.21037\/atm-22-2583","article-title":"Soluble guanylate\ncyclase (sGC) stimulator vericiguat alleviates myocardial ischemia-reperfusion\ninjury by improving microcirculation","volume":"10","author":"Cai","year":"2022","journal-title":"Ann. Transl.\nMed."},{"key":"2026073102164060200_cit6","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1111\/bph.15333","article-title":"Stimulation of soluble guanylyl cyclase\n(sGC) by riociguat attenuates heart failure and pathological cardiac\nremodelling","volume":"179","author":"Ru\u0308debusch","year":"2022","journal-title":"Br. J. Pharmacol."},{"key":"2026073102164060200_cit7","doi-asserted-by":"publisher","first-page":"4130","DOI":"10.1111\/bph.15698","article-title":"Soluble GC stimulators\nand activators: Past, present and future","volume":"181","author":"Sandner","year":"2024","journal-title":"Br.\nJ. Pharmacol."},{"key":"2026073102164060200_cit8","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/s41569-022-00741-6","article-title":"Sulfide\nregulation of cardiovascular function in health and disease","volume":"20","author":"Kolluru","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"key":"2026073102164060200_cit9","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.bcp.2017.11.011","article-title":"The role\nof hydrogen sulfide in cyclic nucleotide signaling","volume":"149","author":"Cao","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"2026073102164060200_cit10","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1002\/j.2040-4603.2017.tb00754.x","article-title":"Protective\nactions of H2S in acute myocardial infarction and heart\nfailure","volume":"7","author":"Donnarumma","year":"2017","journal-title":"Compr. Physiol."},{"key":"2026073102164060200_cit11","doi-asserted-by":"publisher","first-page":"106834","DOI":"10.1016\/j.phrs.2023.106834","article-title":"Hydrogen sulfide\nregulates the redox state of soluble guanylate cyclase in CSE\u2013\/\u2013\nmice corpus cavernosum microcirculation","volume":"194","author":"Olivencia","year":"2023","journal-title":"Pharmacol.\nRes."},{"issue":"10","key":"2026073102164060200_cit12","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1161\/ATVBAHA.110.209783","article-title":"Hydrogen sulfide is an endogenous inhibitor of phosphodiesterase\nactivity","volume":"30","author":"Bucci","year":"2010","journal-title":"Arterioscler., Thromb., Vasc. Biol."},{"key":"2026073102164060200_cit13","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.3389\/fphar.2018.01066","article-title":"Hydrogen sulfide (H2S)-releasing\ncompounds: therapeutic potential in cardiovascular diseases","volume":"9","author":"Zhang","year":"2018","journal-title":"Front. Pharmacol"},{"key":"2026073102164060200_cit14","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1161\/CIRCULATIONAHA.107.753467","article-title":"Characterization\nof a novel, water-soluble hydrogen\nsulfide\u2013releasing molecule (GYY4137)","volume":"117","author":"Li","year":"2008","journal-title":"Circulation"},{"key":"2026073102164060200_cit15","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1002\/med.21913","article-title":"Progress and\nperspective on hydrogen sulfide donors\nand their biomedical applications","volume":"42","author":"Song","year":"2022","journal-title":"Med. Res.\nRev."},{"issue":"3","key":"2026073102164060200_cit16","doi-asserted-by":"publisher","first-page":"429","DOI":"10.3390\/antiox10030429","article-title":"Trends in\nH2S-donors chemistry and their\neffects in cardiovascular diseases","volume":"10","author":"Corvino","year":"2021","journal-title":"Antioxidants"},{"key":"2026073102164060200_cit17","doi-asserted-by":"publisher","first-page":"7512","DOI":"10.1021\/acs.jmedchem.7b00888","article-title":"Iminothioethers as hydrogen sulfide\ndonors: from the\ngasotransmitter release to the vascular effects","volume":"60","author":"Barresi","year":"2017","journal-title":"J. Med. Chem."},{"key":"2026073102164060200_cit18","doi-asserted-by":"publisher","first-page":"13610","DOI":"10.1021\/jacs.9b06319","article-title":"Cyclic\nsulfenyl thiocarbamates release\ncarbonyl sulfide and hydrogen sulfide independently in thiol-promoted\npathways","volume":"141","author":"Zhao","year":"2019","journal-title":"J. Am. Chem. Soc."},{"key":"2026073102164060200_cit19","doi-asserted-by":"publisher","first-page":"7280","DOI":"10.1021\/acs.jmedchem.2c02082","article-title":"New generation of sGC stimulators:\ndiscovery of imidazo[1,2-a]pyridine carboxamide BAY 1165747 (BAY-747),\na long-acting soluble guanylate cyclase stimulator for the treatment\nof resistant hypertension","volume":"66","author":"Vakalopoulos","year":"2023","journal-title":"J. Med. Chem."},{"key":"2026073102164060200_cit20","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/s41586-019-1584-6","article-title":"Structural insights into the mechanism\nof human soluble guanylate cyclase","volume":"574","author":"Kang","year":"2019","journal-title":"Nature"},{"key":"2026073102164060200_cit21","doi-asserted-by":"publisher","first-page":"5492","DOI":"10.1038\/s41467-021-25617-0","article-title":"Activation\nmechanism of human soluble\nguanylate cyclase by stimulators and activators","volume":"12","author":"Liu","year":"2021","journal-title":"Nat. Commun."},{"key":"2026073102164060200_cit22","doi-asserted-by":"publisher","first-page":"5470","DOI":"10.1021\/acs.jmedchem.9b00352","article-title":"Design, synthesis,\nand preclinical efficacy of novel\nnonretinoid antagonists of retinol-binding protein 4 in the mouse\nmodel of hepatic steatosis","volume":"62","author":"Cioffi","year":"2019","journal-title":"J. Med. Chem."},{"key":"2026073102164060200_cit23","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41569-021-00646-w","article-title":"Transforming\ngrowth factor-\u03b2 in myocardial disease","volume":"19","author":"Frangogiannis","year":"2022","journal-title":"Nat. Rev. Cardiol."},{"key":"2026073102164060200_cit24","doi-asserted-by":"publisher","first-page":"116534","DOI":"10.1016\/j.biopha.2024.116534","article-title":"The isoproterenol-induced myocardial\nfibrosis: A biochemical and histological investigation","volume":"174","author":"Flori","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"2026073102164060200_cit25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/4105382","article-title":"Hydrogen\nsulfide as a potential alternative\nfor the treatment of myocardial fibrosis","volume":"2020","author":"Kang","year":"2020","journal-title":"Oxid.\nMed. Cell. Longevity"},{"key":"2026073102164060200_cit26","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1124\/pr.117.014050","article-title":"International\nUnion of Basic and Clinical Pharmacology.\nCII: Pharmacological modulation of H2S levels: H2S donors and H2S biosynthesis inhibitors","volume":"69","author":"Szabo","year":"2017","journal-title":"Pharmacol. Rev."},{"key":"2026073102164060200_cit27","doi-asserted-by":"publisher","first-page":"9672","DOI":"10.1002\/anie.201104236","article-title":"A fluorescent\nprobe for fast and\nquantitative detection of hydrogen sulfide in blood","volume":"50","author":"Peng","year":"2011","journal-title":"Angew. Chem., Int. Ed. Engl."}],"container-title":["Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jmedchem.5c02191","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/68\/18\/19781\/66296028\/acs.jmedchem.5c02191.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/68\/18\/19781\/66296028\/acs.jmedchem.5c02191.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T06:16:49Z","timestamp":1785478609000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article\/68\/18\/19781\/5234849\/Discovery-of-a-Novel-COS-H2S-Donor-Hybridized-sGC"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,11]]},"references-count":27,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2025,9,11]]},"published-print":{"date-parts":[[2025,9,25]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.jmedchem.5c02191","relation":{},"ISSN":["0022-2623","1520-4804"],"issn-type":[{"value":"0022-2623","type":"print"},{"value":"1520-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,11]]}}}